Kazuyuki Inoue
Ogawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Influence of Organic Cation Transporter 3 (SLC22A3) Genetic Polymorphisms on Antidepressant Maintenance Doses in Japanese Patients with Depression.
Journal: Neuropsychobiology
Published: February 26, 2025
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD.
Journal: Journal of diabetes investigation
Published: January 22, 2024
A Pregnant Woman with Excess Vasopressinase-Induced Diabetes Insipidus Complicated by Central Diabetes Insipidus like Lymphocytic Infundibulo-Neurohypophysitis.
Journal: Case reports in endocrinology
Published: May 01, 2023
Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 19, 2021
Pyogenic liver abscess caused by Fusobacterium nucleatum with an inflammatory scar in the abdominal cavity.
Journal: Clinical journal of gastroenterology
Published: December 25, 2020
Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control.
Journal: Journal of diabetes and its complications
Published: October 28, 2020
New possibilities for egg white lysozyme: heat-denatured lysozyme partially inactivates select foot-and-mouth disease virus strains.
Journal: Scientific reports
Published: July 21, 2020
Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
Journal: Endocrine journal
Published: February 15, 2019
Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study.
Journal: Journal of clinical medicine research
Published: May 27, 2018
Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo.
Journal: Drug metabolism and pharmacokinetics
Published: January 31, 2018
Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial.
Journal: Diabetes care
Published: March 13, 2017
Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study.
Journal: Journal of clinical medicine research
Published: December 20, 2016
Last Updated: 09/26/2026